The Phosphodiesterase Inhibitor Cilostazol Induces Regression of Carotid Atherosclerosis in Subjects With Type 2 Diabetes Mellitus

Cilostazol Activates AMP-activated Protein Kinase and Restores Endothelial Function in Diabetes

(2008) K. Suzuki et al.   AMERICAN JOURNAL OF HYPERTENSION

Cilostazol Inhibits Oxidative Stress–Induced Premature Senescence Via Upregulation of Sirt1 in Human Endothelial Cells

(2008) Hidetaka Ota et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Antiplatelet Cilostazol Is Beneficial in Diabetic and/or Hypertensive Ischemic Stroke Patients

(2008) Yukito Shinohara et al.   CEREBROVASCULAR DISEASES

Cilostazol and peripheral arterial disease

(2008) Lyndsay Pearce et al.   EXPERT OPINION ON PHARMACOTHERAPY

Low-Dose Aspirin for Primary Prevention of Atherosclerotic Events in Patients With Type 2 DiabetesA Randomized Controlled Trial

(2008) Hisao Ogawa   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

SIRT1 Modulation of the Acetylation Status, Cytosolic Localization, and Activity of LKB1

(2008) Fan Lan et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

SIRT1 Regulates Hepatocyte Lipid Metabolism through Activating AMP-activated Protein Kinase

(2008) Xiuyun Hou et al.   JOURNAL OF BIOLOGICAL CHEMISTRY